tiprankstipranks
Trending News
More News >
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market

Seres Therapeutics (MCRB) Technical Analysis

Compare
1,065 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Seres Therapeutics’s (MCRB) Moving Averages Convergence Divergence (MACD) indicator is -0.51, suggesting Seres Therapeutics is a Sell.
Seres Therapeutics’s (MCRB) 20-Day exponential moving average is 7.68, while Seres Therapeutics’s (MCRB) share price is $8.23, making it a Buy.
Seres Therapeutics’s (MCRB) 50-Day exponential moving average is 9.27, while Seres Therapeutics’s (MCRB) share price is $8.23, making it a Sell.

Seres Therapeutics (MCRB) Pivot Points

Jun 07, 2025, 06:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.79
6.90
7.08
7.18
7.36
7.47
7.65
Fibonacci
6.90
7.01
7.07
7.18
7.29
7.36
7.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (MCRB) Moving Averages

Jun 07, 2025, 06:57 PM
Period
Simple
Exponential
MA5
7.32Buy
7.51Buy
MA10
7.27Buy
7.42Buy
MA20
7.40Buy
7.68Buy
MA50
9.28Sell
9.27Sell
MA100
12.39Sell
11.45Sell
MA200
14.73Sell
14.04Sell
Seres Therapeutics’s (MCRB) 10-Day exponential moving average is 7.42, while Seres Therapeutics’s (MCRB) share price is $8.23, making it a Buy.
Seres Therapeutics’s (MCRB) 100-Day exponential moving average is 11.45, while Seres Therapeutics’s (MCRB) share price is $8.23, making it a Sell.
Seres Therapeutics’s (MCRB) stock price is $8.23 and Seres Therapeutics’s (MCRB) 50-day simple moving average is 9.28, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $8.23 and Seres Therapeutics’s (MCRB) 100-day simple moving average is 12.39, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $8.23 and Seres Therapeutics’s (MCRB) 200-day simple moving average is 14.73, creating a Sell signal.

Seres Therapeutics (MCRB) Technical Indicators

Jun 07, 2025, 06:57 PM
Name
Value
Implied Action
RSI (14)
52.26
Neutral
STOCH (9,6)
59.20
Neutral
STOCHRSI (14)
53.40
Neutral
MACD (12,26)
-0.51
Sell
ADX (14)
18.51
Buy
Williams %R
-6.25
Sell
CCI (14)
120.48
Sell
ATR (14)
0.70
-
Ultimate Oscillator
59.20
Neutral
ROC
10.32
Buy
Seres Therapeutics’s (MCRB) Relative Strength Index (RSI) is 52.26, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Trend Strength Indicator (ADX) is 18.51, creating a Buy signal.
Seres Therapeutics’s (MCRB) Commodity Channel Index (CCI) is 120.48, creating a Sell signal.
Seres Therapeutics’s (MCRB) Price Rate of Change (ROC) is 10.32, creating a Buy signal.

FAQ

Is MCRB a Buy, Hold, or Sell?
Based on MCRB’s technical indicators, MCRB is a Hold.
    What is MCRB’s RSI (14)?
    MCRB’s RSI (14) is 52.26, which suggests MCRB is a Neutral.
      What is MCRB’s MACD?
      MCRB’s MACD is -0.51, which suggests MCRB is a Sell.
        What is MCRB’s 5-day moving average?
        MCRB’s 5-day moving average is 7.32, which suggests MCRB is a Buy.
          What is MCRB’s 20-day moving average?
          MCRB 20-day moving average is 7.40, which suggests MCRB is a Buy.
            What is MCRB’s 50-day moving average?
            MCRB’s 50-day moving average is 9.28, which suggests MCRB is a Sell.
              What is MCRB’s 200-day moving average?
              MCRB’s 200-day moving average is 14.73, which suggests MCRB is a Sell.
                What is MCRB’s Williams % R (14)?
                MCRB’s Williams % R (14) is -6.25, which suggests MCRB is a Sell.
                  What is MCRB’s CCI (14)?
                  MCRB’s CCI (14) is 120.48, which suggests MCRB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis